{"lastClose": 5.090000152587891, "len": 1126, "date": "2023-04-03", "alpha_1": -0.4290194822955863, "beta_1": 1.5379722856095366, "drawup_1": 1.5486725887776869, "natr_1": 16.017203563628993, "sup_1": -0.007203769530337352, "res_1": 0.5867714009631424, "bullPattern_1": ["SHORTLINE", "SPINNINGTOP"], "bearPattern_1": [], "rsi_1": 24.33154821129956, "adx_1": 30.722413378254966, "drawdown_1": -0.7152777846764633, "stratHoldSharpe_1": -0.4680405449705901, "stratHoldAlpha_1": 250.68641006080097, "stratHoldDrawdown_1": -0.674304427803264, "alpha_3mo": -0.8091718906058762, "beta_3mo": 1.7590133958098382, "drawup_3mo": 0.38448571261546305, "natr_3mo": 16.017203563628993, "sup_3mo": -0.07531107144025916, "res_3mo": 0.16371967571826607, "bullPattern_3mo": ["BELTHOLD", "LONGLINE"], "bearPattern_3mo": ["HIKKAKE"], "rsi_3mo": 30.59702475103952, "adx_3mo": 35.59357445346764, "drawdown_3mo": -0.40073080956959317, "stratHoldSharpe_3mo": -0.9822504924568277, "stratHoldAlpha_3mo": 250.46217167962538, "stratHoldDrawdown_3mo": -0.37021754780048044, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "Name": "Allogene Therapeutics Inc.", "Market Cap": 734029684, "Country": "United States", "Sector": "Health Care", "alpha%_1": 0.098110036668137, "beta%_1": 0.8757551608904492, "drawup%_1": 0.9975566775584284, "natr%_1": 0.9999997767935922, "drawdown%_1": 0.040454397286389145, "stratHoldSharpe%_1": 0.28439492913164477, "stratHoldAlpha%_1": 0.12926020581313669, "stratHoldDrawdown%_1": 0.02969232046664907, "alpha%_3mo": 0.1059429190000935, "beta%_3mo": 0.8994358701552003, "drawup%_3mo": 0.9325914618481178, "natr%_3mo": 0.9999995642020961, "drawdown%_3mo": 0.035673591968262496, "stratHoldSharpe%_3mo": 0.22012746810564743, "stratHoldAlpha%_3mo": 0.1429823868003029, "stratHoldDrawdown%_3mo": 0.03323842679741971}